Protease digested royal jelly pharmacokinetics study in healthy volunteers.
- Conditions
- Adult
- Registration Number
- JPRN-UMIN000029627
- Lead Sponsor
- Yamada Bee Company, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
The subjects in conflict with any of the following condition are excluded. 1) A person who has a food allergy 2) A person who has an asthma 3) A women who is pregnant, hope for the pregnancy, or breastfeeding 4) A parson who participated in other clinical trial at resent (past 3 months) 5) A person who has the infectious disease 6) A person with a history of the surgery considerable in the gastrointestinal tract site, for example, gastrectomy, stomach and intestines suturation, intestinal tract resection and so on. 7) A person who with the disease to liver, kidney, heart, diabetes and serious desease 8) A person who has received medical treatment of drug now 9) A person who can not visit the designated examination date (including the previous night) and be hospitalized until the trial end. 11) A person who Those who can not quit smoking from dinner the day before the examination to the examination end 12) A person who cannot take in royal jelly according to instruction or cannot maintain rest until the trial end. 13) A person who can not ban the intake of royal jelly-containing food from one week before the clinical trial. 14) A person who cannot keep regular hours 15) A person who is not daily service (who is night or rotation duty) 16) A person who has taken the blood sampling 200 mL within 4 weeks or 400 mL within 3 months at the time of starting this trial 17) A person who is a heavy alcohol drinker (over 500 mL beer per day ) 18) A person who is a heavy smorker (over 20 cigarettes per day) 19) A person who dentified as improper by the principal investigator or subinvestigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method